WWOX and cancer: Alteration of WWOX has been observed in many tumors, including breast [28], ovarian [22], prostate [29], lung [16], hepatocellular [30], gastric [31], and other cancers [32–35], and loss or reduction of its expression is reported to be correlated with worse clinical prognosis such as breast and ovarian cancer [28, 36].